| Issue |
Section |
Title |
File |
| Vol 16, No 1S (2009) |
Articles |
ANTIANGIOGENNYE PREPARATY V LEChENII RAKA MOLOChNOY ZhELEZY |
|
| Vol 20, No 8 (2013) |
Articles |
ROL' IMMUNOKON\"YuGATOV V TARGETNOY TERAPII ZLOKAChESTVENNYKh OPUKhOLEY |
|
| Vol 22, No 8 (2015) |
Articles |
KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY |
|
| Vol 23, No 8 (2016) |
Articles |
NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER |
|
| Vol 23, No 17 (2016) |
Articles |
TAXANES IN THE TREATMENT OF BREAST CANCER |
|
| Vol 24, No 17 (2017) |
Articles |
De-escalation and escalation of treatment of patients with HER2-positive breast cancer |
|
| Vol 24, No 17 (2017) |
Articles |
New possibilities of the treatment of breast cancer: microtubule inhibitors |
|
| Vol 25, No 7 (2018) |
Articles |
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER |
|
| Vol 25, No 12 (2018) |
Articles |
Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities |
|
| Vol 27, No 7 (2020) |
Articles |
Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study |
|
| Vol 27, No 7 (2020) |
Articles |
Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors |
|
| Vol 29, No 7 (2022) |
Articles |
Clinical immunology of breast cancer |
|
| Vol 29, No 7 (2022) |
Articles |
Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer |
|
